Mandatory Notification (MN) of Mesotheliomas

Size: px
Start display at page:

Download "Mandatory Notification (MN) of Mesotheliomas"

Transcription

1 Maladies chroniques et traumatismes September 2014 Occupational health Mandatory Notification (MN) of Mesotheliomas 2012, First Year of the Program s Nationwide Operation Laurence Chérié-Challine, Nathalie Bonnet, Ellen Imbernon, with the participation of Céline Gallot Department of Occupational Health (DST), French Institute for Public Health Surveillance (InVS), Saint-Maurice, France. Mandatory Notification (MN) of Mesotheliomas 2012, First Year of the Program's Nationwide Operation After Laurence a pilot Mandatory phase Chérié-Challine, in 2011 Notification in 6 volunteer Nathalie (MN) Bonnet, regions, of Mesotheliomas mesothelioma Ellen Imbernon Department to implement of Occupational the Meso-MN Health, surveys French to improve Institute knowledge for Public became Health 2012, the Surveillance 31st First mandatory Year of the notification Program's disease Nationwide in France, Operation about occupational and environmental exposure in 3 by decree (n , January 16, 2012). This mandatory populations that experts know too little about: individuals notification with the Laurence requirement participation Chérié-Challine, applies of Céline to Nathalie all Gallot, doctors Bonnet, Department (pathologists Ellen Imbernon of Occupational and Department with Health, non-pleural of Occupational French mesothelioma, Institute Health, for French Public men Institute Health younger for Surveillance than Public 50, and clinicians) After Health a practicing pilot Surveillance phase in in metropolitan 2011 in 6 volunteer or overseas regions, France mesothelioma who women became with the pleural 31 st mandatory mesothelioma. notification disease in France, diagnose by decree a case (n , of mesothelioma, January 16, regardless 2012). This of its mandatory anatomic notification requirement applies to all doctors (pathologists and with the participation of Céline Gallot, Department of Occupational Health, French Institute for Public Health Surveillance site. clinicians) It is part of practicing the second in national metropolitan Cancer or Plan overseas and contributes France who diagnose This knowledge a case should of mesothelioma, help us to guide regardless community of its prevention anatomic After a pilot phase in 2011 in 6 volunteer regions, mesothelioma became the 31 st mandatory notification disease in France, more site. widely It by is decree part to measures of (n , the second against January national asbestos-related 16, 2012). Cancer This Plan cancers, mandatory and contributes an notification activities more requirement and widely increase to applies important medical to all steps doctors and social against (pathologists recognition asbestos-related and for the important cancers, clinicians) public an important health practicing problem. public in metropolitan health problem. or overseas France who diagnose benefit a of case individual of mesothelioma, patients. regardless The PNSM, of its in operation anatomic since site. It is part of the second national Cancer Plan and contributes 1998, more is widely the reference to important system steps for against monitoring asbestos-related and knowledge Established Established cancers, by the by an French the important French Institute public Institute for health Public for problem. Health Public Surveillance Health Surveillance of pleural (InVS) mesothelioma; at Ministry nonetheless of Health s it request cannot and describe applying the (InVS) recommendations the Ministry of of the Health s High Council request of and Public applying Health (HCSP), pleural mesothelioma mandatory notification situation of in mesothelioma districts it does has two not recommendations objectives Established intended of by the the to High further French Council Institute epidemiological of Public for Public Health knowledge: Health (HCSP), Surveillance cover. (InVS) Mandatory at the Ministry notification of Health s completes request and the applying PNSM for the recommendations of High Council of Public Health (HCSP), mandatory notification of mesothelioma has two mandatory - To use notifications of from mesothelioma doctors to strengthen has two objectives the monitoring other of all mesotheliomas, sites, to especially complete peritoneum. national program It is not of objectives intended to further epidemiological knowledge: intended mesothelioma to further surveillance epidemiological (PNSM), knowledge: which covers only cases of an pleural expert-based mesothelioma system and and only cannot in 21 districts. replace the system for - To use notifications from doctors to strengthen the monitoring of all mesotheliomas, to complete the national program of - To implement the Meso-MN surveys to improve knowledge mesothelioma surveillance (PNSM), which covers only cases of pleural reporting about mesothelioma occupational and only diseases. and environmental exposure in 3 in 21 districts. to populations use notifications - To implement that from experts the doctors Meso-MN know to strengthen too surveys little about: the to monitoring improve individuals knowledge with about non-pleural occupational mesothelioma, and environmental men younger exposure than in 3 50, and of women all mesotheliomas, populations with pleural that mesothelioma. to experts complete know the too national little about: program individuals of with non-pleural mesothelioma, men younger than 50, and mesothelioma women with surveillance pleural mesothelioma. (PNSM), which covers only cases of This pleural knowledge mesothelioma should and help only us to in 21 guide districts. community prevention activities, and increase medical and social recognition for the benefit This knowledge of individual should help patients. us to guide The PNSM, community in operation prevention activities, since 1998, and increase is the reference medical and system social recognition for monitoring for and knowledge the benefit of pleural of individual mesothelioma; patients. nonetheless The PNSM, in it operation cannot describe since 1998, the pleural is the reference mesothelioma system situation for monitoring in the and districts it does knowledge not cover. of Mandatory pleural mesothelioma; notification nonetheless completes the it cannot PNSM describe for the other pleural mesothelioma sites, situation especially in the the districts peritoneum. It does not cover. Mandatory notification completes the PNSM for the other mesothelioma sites, especially the peritoneum. It I is Figure not an is not 1 expert-based I system and cannot replace the system for reporting occupational diseases. an expert-based system and cannot replace the system for reporting occupational diseases. The The two two The components two components components of the of of the national the national national mesothelioma mesothelioma mesothelioma MN system MN MN system system The first component: national epidemiological surveillance (notification) The first component: national epidemiological surveillance (notification) French Institute for Public Health Surveillance / p. 1 1

2 The first component: national epidemiological surveillance (notification) Strong involvement of all MN participants The project is coordinated by the InVS and was developed with support from the relevant institutions (Directorate-General of Health DGS, Directorate-General of Labor DGT, and National Cancer Institute INCa). Representatives of these institutions and of various organizations and professional groups (French Society of Pathology (SFP), French-language Society of Pulmonary Medicine (SPLF), National Council of Oncology (CNC), and the National Network for rare peritoneal tumors (RENAPE), the National Reference Centre for pleural mesothelioma (Mesoclin), and Expert Pathologists Network for Mesothelioma (Mesopath)) sit on the project steering committee (COPIL). Their participation enables the communication, cooperation, and guidance necessary for the development and effective operation of the program. The MN system is organized on a regional basis, with the interregional epidemiology groups (Cellules interrégionales d épidémiologie) (CIRE-InVS), the regional health agencies (Agences régionale de santé) (ARS), regional oncology networks (RRC), and in association with the PNSM team in the regions concerned. The InVS, with its national and regional partners, is conducting numerous communication activities aimed at increasing awareness and ination among all doctors who may potentially see cases that must be notified. The regional oncology network plays an essential role in local communication, through its regional networks of potential notifiers, and seeks the active participation of all doctors who diagnose mesothelioma. Awareness among gastroenterologists is also facilitated by the national network of rare peritoneal tumors (RENAPE). Satisfactory results for 2012, the first year of notification The early results concern 618 new cases of mesothelioma diagnosed histologically in 2012 and reported through the MN program from January 2012 (when it began) to April 30, The end date is consistent with the mean notification delay of 4 months, observed during the first 6 months of notification in We note that the data presented probably do not reflect the real situation, especially in view of the non-exhaustive participation of all doctors who might diagnose mesothelioma and the permanent and developing nature of the MN system. Thus, between May 2013 and February 15, 2014, the InVS received 41 new reports of mesothelioma cases diagnosed in 2012, for a total of 659 incident cases that year, still below the number expected. I Table 1 I Summary of the characteristics of the cases diagnosed in 2012 and notified between January 2012 and April 30, 2013 Characteristics of notifications Number of cases of mesothelioma: 618 (615 in metropolitan France, 3 in Reunion, 0 in Martinique- Guadeloupe-Guyane) Notifying physicians 781 notification s, transmitted by: - pathologists: 74% - clinicians: 52% Cases notified by a pathologist and a clinician (=notification rule): 22% Mean time until transmission by metropolitan region From date of diagnosis to reception by InVS All notifications: 94 days Notifications from January to June 2012: 124 days (range: 41 to 226 days) Notifications from July to December: 63 days (13 to 116 days) Anatomic site Characteristics of mesothelioma Pleura: 89% (Men: 92% - Women: 83%) Peritoneum: 9% (Men: 7% - Women: 14%) Tunica vaginalis (testes): 2 cases Sex All sites: Men: 73% - Women: 27% Pleura: Men: 75% - Women: 25% Peritoneum: Men 58% - Women: 42% Mean age All sites: Men: 72.6 years - Women: 71.0 years Pleura: 73.4 years - Women: 72.8 years Peritoneum: Men 67.9 years - Women: 64.2 years Younger than 50 years All sites: 2.6% (Men: 1.3% - Women: 6.1%) Pleura: 1.3% (Men: 0.5% - Women: 3.8%) Peritoneum: 16.6% (Men 12.9% - Women 21.7%) p. 2 / French Institute for Public Health Surveillance Mandatory Notification (MN) of Mesotheliomas. 2012, First Year of the Program s Nationwide Operation

3 The ination about known occupational contact with asbestos was reported often When clinicians report the diagnosis directly to the regional health agency, their opinion about occupational contact with asbestos is stated directly on the ; when a pathologist notifies a case, the regional health agency contacts the clinician by telephone to obtain this ination. This variable was reported in 78% of cases. Certain or possible contact is specified in 47%, and absence of known contact in 19%. In 12% of the cases, the clinician could not answer. The level of coverage nationwide on April 30, 2013, ranges from 51% to 77% If we base our assessment on the order of magnitude of the annual number of expected cases of mesothelioma (all sites), from 800 to 1200 (source: INCa), we can consider that nationally, on April 30, 2013, the MN system had recorded 51% to 77% of the cases diagnosed in On February 15, 2014, given the 41 new cases from 2012 notified late, the level of national exhaustiveness had improved by 5%, that is, to 56% to 82%. Substantial differences in the exhaustiveness between regions There were substantial differences in the level of completeness between regions. On April 30, 2013, one third of the regions had come close to complete reporting, with the number of cases from MN of the same order of magnitude as those estimated by the PNSM and mortality similar to that reported by the PMSI and/or Cépi-Dc-INSERM. These regions include Aquitaine, Bourgogne, Limousin, the Midi-Pyrénées, the Nord- Pas-de-Calais, Picardie, and Poitou-Charentes. Inversely, the completeness of reporting remains low in some regions. We note nonetheless that the situation has since changed as a function of the notifications received for each region. The 2012 data from both the PMSI and the causes of death were not available at the time this document was written, so that comparisons were possible only for earlier years (2011 for PMSI and 2010 for mortality). I Table 2 I Comparison between regions for incident cases reported by MN and other surveillance systems DO Incident cases 2012 Range of expected number of incident cases (1) PMSI Cases 2011 (linked since 2004) Mortality Death 2010 Lower-upper range Pathologist national reference center (2) Cases assessed 2012 Alsace Aquitaine Auvergne Basse-Normandie Bourgogne Bretagne Centre Champagne-Ardenne Corse Franche-Comté Haute-Normandie Ile-de-France Languedoc-Roussillon Limousin Lorraine Midi-Pyrénées Nord-Pas-de-Calais Paca Pays de la Loire Picardie Poitou-Charentes Rhône-Alpes Total metropolitan France ,200 1, , (1) National numbers (source INCa), regional order of magnitude based on size of the regional population, without taking the differences in exposure by region into account, although they can be substantial. (2) Regional distribution of cases analyzed by experts, according to the location of the diagnosing pathologist s practice (and not the patient s home), for both primary cancers and recurrences (source Mesopath). French Institute for Public Health Surveillance / p. 3

4 Exhaustiveness must improve further to allow epidemiological surveillance These early results show that the quality of the mesothelioma MN system varies according to region. They should help to guide actions to increase the participation of both pathologists and clinicians. The modalities of its implementation must be debated within COPIL especially for national activities but also for adaptation to the situation in each region, to be discussed with each of the regional project teams. The second component, for knowledge of the exposure factors (Meso-MN surveys) In accordance with the opinion of the High Council of Public Health (HCSP) dated October 21, 2010, the InVS is setting up exposure surveys to strengthen our knowledge of the occupational and environmental factors (asbestos and other fibers) in 3 populations insufficiently known (30% of all mesotheliomas): people with non-pleural mesothelioma; women with pleural mesothelioma; men younger than 50 years with pleural mesothelioma. These Meso-MN surveys are conducted by the Department of Occupational Health (DST-InVS) with the Department of Environmental Health (DSE-InVS), the regional and alert coordination department (DCar-InVS), and the PNSM experts. They are intended to complete the exposure surveys conducted as part of PNSM. Pilot phase conducted in 2014 in 9 regions The Meso-MN surveys are being tested in 2014, for a one-year period, in 8 volunteer regions in metropolitan France (Aquitaine, Alsace, Basse-Normandie, Bretagne, Franche-Comté, Limousin, Picardie, and Poitou-Charentes) and in one overseas region (Reunion). The CNIL approved the study on May 8, 2013 (decision DR ). The patients to be surveyed are identified from the MN s received by the participating regional health agencies. Patients eligible for both the PNSM and Meso-MN surveys (men < 50 years or woman with pleural mesothelioma and living in a PNSM district) are surveyed according to the PNSM procedure. Two regional models are being tested: surveys conducted by the InVS interregional epidemiology teams (CIRE in Bretagne, Limousin, Picardie, Poitou- Charentes, and Reunion); surveys conducted by the local PNSM team, as part of an extension of the PNSM, applying the Meso-MN survey procedure (Alsace, Aquitaine, Basse-Normandie and Franche- Comté). The InVS is collaborating with the occupational health team (ESSAT) of the environmental and occupational health laboratory (Laboratoire-Santé-Travail-Environnement (LSTE)) at the University of Bordeaux: they provide an expert assessment of the exposure of case patients, based on their analysis of the survey answers. A progressive national rollout of these surveys should begin in 2015, depending on the results of the pilot phase The pilot phase will allow us to test all phases of the Meso- MN survey and to assess the time and staff necessary for the perance of each stage. It will allow us to analyze the participation rate in these surveys and the quality of questionnaire completion. It will also allow us to assess the feasibility of these surveys and their relevance for meeting our objective to strengthen knowledge of exposure to asbestos and other fibers. If the outcome is positive, recommendations will be produced for the rollout of these surveys in the other regions, both metropolitan and overseas; it will take place progressively, starting in 2015 in accordance with the local situation in each region and the budget available. In conclusion Through the support of the professional groups and societies and institutions, especially members of the COPIL, and in association with its regional partners, the InVS has been able to establish an effective national surveillance system for mesothelioma, based on a MN system. This system can and must be improved further. It is also essential to continue all together its development. Support for the national epidemiological surveillance program for mesothelioma and the development of exposure surveys are among the points included in action 12-4 ("support epidemiological surveillance and research to improve knowledge of occupational cancers") of the Cancer Plan for , launched by the president of the republic on February 4, This national program includes MN of mesothelioma and the PNSM, two linked systems complementary in terms of their objectives. InVS continues to produce regular reports updating the current epidemiological situation of mesotheliomas in France. The next MN report will cover in particular the consolidated incidence data for 2012 and the incidence data for French Institute for Public Health Surveillance / p. 4

5 Review of the notification procedure for a new case of mesothelioma Definition of a case to be notified The following cases must be notified: all new cases of mesothelioma of the pleura, the peritoneum, the pericardium, the testes vaginalis, or of any other or unspecified site, diagnosed from a pathology examination or a clinical expert assessment in the absence of a histologic examination or confirmation, based on clinical, radiologic, and ultrasound findings. Two notification s: pathologists and clinicians Can be downloaded from the InVS website (http://www. invs.sante.fr). The notifying physician must use the appropriate to his or her specialty (pathologist or clinician) and region of practice (access by pulldown menu - upper right line). Notification procedure The diagnosis is reported after it has been histologically confirmed. It comprises two stages: 1) completion of the (pathologist or clinician ) for the doctor s region of practice; 2) rapid transmission, even if incomplete, dated and signed, by fax to the doctor responsible for mandatory notifications of mesothelioma at the regional health agency of the region of practice (fax number in the regional pulldown menu). The cases to be surveyed All people with non-pleural mesothelioma. Women with pleural mesothelioma. Men younger than 50 years with pleural mesothelioma. I Figure 2 I Notification circuit of a new case of mesothelioma Notifying physicians Notifying pathologists - complete the pathologists with the ination they have available Notifying clinicians - complete the clinicians - in the patient about mandatory notification Pathologists Clinicians Physicians, Regional Health Agency (ARS) - validate the s - contact notifying physician, if necessary - establish anonymous code - send the completed and anonymized - store the identity-code data for 12 months Pathologists anonymized Clinicians anonymized Epidémiologists/InVS - validate the s - match the clinicians and pathologists s - eliminate duplicates - data entry into the national database: quality control national analyses feedback to regions French Institute for Public Health Surveillance / p. 5

6 To learn more 1. L. Chérié-Challine, N. Bonnet, E. Imbernon. Déclaration obligatoire des mésothéliomes : 2012, première année de fonctionnement du dispositif national, rapport InVS Bulletin de rétro-ination n 1 du réseau DO mésothéliomes. 3. Dossier DO sur le site de l InVS : 4. Des indicateurs en santé travail Risques professionnels dus à l amiante. Saint Maurice : Institut de veille sanitaire ; p. Available from the URL: Acknowledgments We thank : - the notifying physicians; - the regional partners (ARS-CVAGS, Cire, RRC, local PNSM team); - the professional societies (SFP, FFP, SPLF, CNC, CPHG, Renape, CNPath, Mesoclin, Mesopath); - the members of the Project steering committee (PJ. Bousquet, A. Buémi, L. Chérié-Challine, F. Capron, PL. Druais, M. Fontaine, F. Galateau-Sallé, A. Gallay, S. Gilardin, A. Gilg Soit Ilg, FN. Gilly, JP. Grignet, E. Imbernon, J. Le Moal, P. Lonchambon, F. Martin, F. May-Levin, C. Merle, T. Molina, JC. Pairon, JC. Sabourin, A. Scherpereel, A. Thuret, V. Trillet-Lenoir, S. Urban, L. Villeneuve). Key words: Mandatory notification, mesotheliomas, epidemiological surveillance, exposure surveys, France Suggested citation: Chérié-Challine L, Bonnet N, Imbernon E. Mandatory Notification (MN) of Mesotheliomas. 2012, First Year of the Program s Nationwide Operation. Saint-Maurice (Fra): French Institute for Public Health Surveillance (Institut de veille sanitaire); p. Available from the URL: French Institute for Public Health Surveillance (Institut de veille sanitaire), 12 rue du Val d Osne Saint-Maurice Cedex France Tel.: 33 (0) Fax: 33 (0) ISSN: ISBN-NET: Design/Production: Communication department InVS Legal deposit: september 2014

Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec *

Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec * Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec * SUMMARY AND RECOMMENDATIONS OF THE REPORTS ABSTRACT In 1997, in light of international developments

More information

Indicators in Occupational Health

Indicators in Occupational Health Indicators in Health Indicators in Occupational Health Occupational risks due to asbestos Sommaire Abreviations 2 Presentation 3 1. Introduction: Asbestos, exposure, health effects 4 1.1 Asbestos: nature

More information

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image

More information

1. 2. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS

1. 2. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS SERVIR L AVENIR * 1. 2. 3. 4. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS OUR NETWORK AT THE HEART

More information

Annual Report 2011. Organisation for the Register of Insurance Intermediaries

Annual Report 2011. Organisation for the Register of Insurance Intermediaries Organisation for the Register of Insurance Intermediaries Annual Report 2011 A r t i c l e R. 5 1 2-5 V I I I o f t h e F r e n c h I n s u r a n c e C o d e 1, r u e J u l e s L e f e b v r e 7 5 3 1

More information

Pathology of Malignant Mesothelioma

Pathology of Malignant Mesothelioma Pathology of Malignant Mesothelioma Françoise Galateau-Sallé Pathology of Malignant Mesothelioma With 169 Figures, 158 in Full Color International Mesothelioma Panel Elisabeth Brambilla, Philip T. Cagle,

More information

H E A D O F F I C E A N D L A B O R A T O R I E S

H E A D O F F I C E A N D L A B O R A T O R I E S INERIS in brief INERIS in a few words F O U N D E D I N 1 9 9 0 INERIS remit is to carry out, or to have carried out, studies and research that make it possible to prevent the risks that economic activities

More information

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Survey of Mesothelioma Associated with Asbestos Exposure in Japan The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics

More information

Health effects of occupational exposure to asbestos dust

Health effects of occupational exposure to asbestos dust Health effects of occupational exposure to asbestos dust Authors: N.Szeszenia-Dąbrowska, U.Wilczyńska The major health effects of workers' exposure to asbestos dust include asbestosis, lung cancer and

More information

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum Occupational respiratory diseases due to Asbestos Dirk Dahmann, IGF, Bochum Contents Introduction Diseases Further Effects Preventive Strategies Conclusion Asbestos minerals Woitowitz, 2003 Imports (+

More information

Electronic medical records

Electronic medical records Electronic medical records Country: France Partner Institute: Institut de Recherche et Documentation en Economie de la Santé (IRDES), Paris Survey no: (8)2006 Author(s): Chantal Cases, Philippe Le Fur

More information

Preventive health-care system in France : Organisation, financement

Preventive health-care system in France : Organisation, financement Preventive health-care system in France : Organisation, financement Dr Martine Le Quellec-Nathan Sous-directrice Direction générale de la Santé Ministère de la santé et de la protection sociale VHPB Veyrier

More information

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA 1 CUTTING-EDGE ISSUES IN ASBESTOS LITIGATION CONFERENCE Scott Masterson Lewis, Brisbois, Bisgaard & Smith, LLP 1180 Peachtree Street, NE, Suite 2900

More information

Table 2.4. Summary of design and findings from mesothelioma case-control studies

Table 2.4. Summary of design and findings from mesothelioma case-control studies categories Agudo et al. (2000) Barcelona and Cadiz, Spain 32 cases (77% males) of histologically con rmed malignant pleural mesothelioma identified from hospital in the region between //993 and 2/3/996.

More information

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden 596500SJP0010.1177/1403494815596500B. Järvholm and A. BurdorfAsbestos ban reduces mesothelioma incidence research-article2015 Scandinavian Journal of Public Health, 1 7 Original Article Emerging evidence

More information

Mesothelioma: Questions and Answers

Mesothelioma: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions

More information

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos: A health hazard Exposure to asbestos was a major occupational health hazard in the United States. The first large-scale

More information

Insee. French National Institute of Statistics and Economic Studies. English edition. www.insee.fr. Fourth quarter 2010

Insee. French National Institute of Statistics and Economic Studies. English edition. www.insee.fr. Fourth quarter 2010 Insee French National Institute of Statistics and Economic Studies Fourth quarter 2010 English edition Historical summary France established its first statistical agency, Statistique Générale de la France,

More information

Malignant Mesothelioma

Malignant Mesothelioma Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)

More information

Munich Cancer Registry

Munich Cancer Registry Munich Cancer Registry Baseline statistics Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, 81377 Germany http://www.tumorregister-muenchen.de/en

More information

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results. Proposed PAHO Plan of Action for Cancer Prevention and Control 2008 2015 Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

More information

Association de Science Régionale De Langue Française LOOKING FOR REGIONAL DISPARITIES

Association de Science Régionale De Langue Française LOOKING FOR REGIONAL DISPARITIES Association de Science Régionale De Langue Française XLème Colloque de l ASRDLF Convergence et disparités régionales au sein de l espace européen Les politiques régionales à l épreuve des faits Bruxelles

More information

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc.

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc. Scientific Update on Safe Use of Asbestos Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc.org When We Talk about Asbestos What Do We Mean? Anthophyllite

More information

australian mesothelioma registry

australian mesothelioma registry australian mesothelioma registry 1st Annual Report Mesothelioma in Australia 2011 The Australian Mesothelioma Registry is funded by Safe Work Australia and Comcare. Creative Commons ISBN 978-0-642-78563-3

More information

Sir William Osler: Listen to the patient; the patient tells you everything.

Sir William Osler: Listen to the patient; the patient tells you everything. Sir William Osler: Listen to the patient; the patient tells you everything. Jean-Martin Charcot: The patient is a liar. Epidemiology of Mesothelioma Jeffrey H. Mandel, MD, MPH Division of Environmental

More information

MESOTELIOMA and CHRYSOTILE

MESOTELIOMA and CHRYSOTILE MESOTELIOMA and CHRYSOTILE in RUSSIA Kashansky S.V., Grinberg L.M., Kuzmin S.V., Berdnikov R.B., Berzin S.A. Ekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

More information

FITCH AFFIRMS GROUPE BPCE AT 'A+'

FITCH AFFIRMS GROUPE BPCE AT 'A+' FITCH AFFIRMS GROUPE BPCE AT 'A+' Fitch Ratings-London-11 October 2011: Fitch Ratings has affirmed Groupe BPCE's (GBCPE), BPCE S.A.'s (GBPCE's central body) and Natixis's Long-term Issuer Default Ratings

More information

The French National Program for Mesothelioma Surveillance

The French National Program for Mesothelioma Surveillance Occupational Health The French National Program for Mesothelioma Surveillance Principal results 1998-2006 Institut interuniversitaire de médecine du travail de Paris Île-de-France Contents 1. Main features

More information

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.

More information

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* M. L. Newhouse TUC Centenary Institute of Occupational Health London School of Hygiene and Tropical Medicine London WCIE 7HT. England G. Berry

More information

Chronic pain: identification, assessment and referral of patient with chronic pain syndrome

Chronic pain: identification, assessment and referral of patient with chronic pain syndrome CLINICAL PRACTICE GUIDELINE Chronic pain: identification, assessment and referral of patient with chronic pain syndrome Formal consensus GUIDELINE December 2008 The scientific report to this guidelinecan

More information

KAISER ALUMINUM & CHEMICAL CORPORATION ASBESTOS PERSONAL INJURY TRUST

KAISER ALUMINUM & CHEMICAL CORPORATION ASBESTOS PERSONAL INJURY TRUST KAISER ALUMINUM & CHEMICAL CORPORATION ASBESTOS PERSONAL INJURY TRUST Dual Claimants Frequently Asked Questions Q. How does the Trust review a lung cancer claim where the injured party also had silica

More information

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR) THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR) Professor Nico van Zandwijk Director Asbestos Diseases Research Institute US US UK UK COUNTRY NZ CAN COUNTRY NZ CAN AUS AUS Mesothelioma International context

More information

Asbestos and the diseases it causes

Asbestos and the diseases it causes Asbestos and the diseases it causes October 2013 Liz Darlison Mesothelioma UK University Hospitals of Leicester Contents What is asbestos Why is it such an issue in the UK Disease Statistics Asbestos Related

More information

ASBESTOS-RELATED DISEASES IN QUEBEC

ASBESTOS-RELATED DISEASES IN QUEBEC REPORT THE EPIDEMIOLOGY OF ASBESTOS-RELATED DISEASES IN QUEBEC SUB-COMMITTEE ON THE EPIDEMIOLOGY OF ASBESTOS-RELATED DISEASES IN QUEBEC JULY 2004 AUTHORS Members of the sub-committee on the epidemiology

More information

Market Presentation: France. Guy-Antoine de La Rochefoucauld Country Manager. October 2010. > www.lloyds.com/marketpresentations

Market Presentation: France. Guy-Antoine de La Rochefoucauld Country Manager. October 2010. > www.lloyds.com/marketpresentations Market Presentation: France Guy-Antoine de La Rochefoucauld Country Manager October 010 > www.lloyds.com/marketpresentations About Lloyd s France > Setting the Scene > Review of Lloyd s in France 1 Content

More information

PREVENTION OF OCCUPATIONAL DISEASES

PREVENTION OF OCCUPATIONAL DISEASES THE PREVENTION OF OCCUPATIONAL DISEASES World Day for safety and health at work 28 April 2013 Outline The hidden epidemic: a global picture Assessing the need for better data Steps for the prevention of

More information

A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008

A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008 A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine 108 Cherry Street, PO Box 70 Burlington, VT 05402 802.863.7200 healthvermont.gov A Cross-Sectional

More information

FITCH DOWNGRADES MAJOR FRENCH BANKS' RELATED ENTITIES

FITCH DOWNGRADES MAJOR FRENCH BANKS' RELATED ENTITIES FITCH DOWNGRADES MAJOR FRENCH BANKS' RELATED ENTITIES Fitch Ratings-Paris/London-17 July 2013: Fitch Ratings has downgraded several of BNP Paribas' (BNPP), Credit Agricole's (CA), Societe Generale's (SG),

More information

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012) Mesothelioma in Australia: Incidence (1982 to 213) and Mortality (1997 to 212) 215 Disclaimer The information provided in this document can only assist you in the most general way. This document does not

More information

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007 MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 28 MORTALITY 1997 TO 27 August 212 Safe Work Australia Mesothelioma in Australia Incidence 1982 to 28 Deaths 1997 to 27 August 212 Acknowledgement Data on the

More information

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011 MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 29 MORTALITY 1997 TO 211 OCTOBER 213 Safe Work Australia Mesothelioma in Australia Incidence 1982 to 29 Mortality 1997 to 211 OCTOBER 213 Acknowledgement Disclaimer

More information

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Disease Markers Volume 2015, Article ID 282145, 5 pages http://dx.doi.org/10.1155/2015/282145 Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Emanuela Taioli,

More information

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER OCCUPATIONAL CANCER EPIDEMIOLOGY Round Table organized by the Public Health Institute from Bucharest Information pack for the participants, provided by dr. Dana

More information

Uses and Abuses of Pathology in Asbestos-exposed Populations

Uses and Abuses of Pathology in Asbestos-exposed Populations Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,

More information

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center Changing Trends in Mesothelioma Incidence Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center International Conference on Chrysotile Montreal, May 23, 2006 Global Mesothelioma

More information

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007 Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update December 7, 2007 Center for Occupational Health and Safety Chronic Disease and Environmental Epidemiology Section Minnesota

More information

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native

More information

ow centres of expertise should interface with social services The French experience : state of the art and current challenges

ow centres of expertise should interface with social services The French experience : state of the art and current challenges ow centres of expertise should interface with social services The French experience : state of the art and current challenges Christel Nourissier EURORDIS EUROPLAN Advisor 2 strategic Plans for rare diseases

More information

Report on our consultancy activities by SLIM on the project 2EP3 for the year

Report on our consultancy activities by SLIM on the project 2EP3 for the year To Institut Régional du Travail Social PACA e Corse 20 Boulevard des Salyens BP 133 13267 Marseille (Cedex 08) FRANCE Report on our consultancy activities by SLIM on the project 2EP3 for the year 2013.

More information

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers Table of Contents WS-E-12 Xing Zhang Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers Xing Zhang 1, Tong-da Sun 2, Nan-feng Shi 2, Li-qiu Zhu 1, Kenji Morinaga 3 1 Institute

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

J of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063 PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi

More information

Plaintiffs Experts Latest Pathological Theories

Plaintiffs Experts Latest Pathological Theories Plaintiffs Experts Latest Pathological Theories Kurt B. Gerstner Campbell Campbell Edwards & Conroy, P.C. One Constitution Center Boston, MA 02129 (617) 241-3086 kgerstner@campbell-trial-lawyers.com Kurt

More information

Transcript for Asbestos Information for the Community

Transcript for Asbestos Information for the Community Welcome to the lecture on asbestos and its health effects for the community. My name is Dr. Vik Kapil and I come to you from the Centers for Disease Control and Prevention, Agency for Toxic Substances

More information

Spectrum Monitoring French Organization and facilities

Spectrum Monitoring French Organization and facilities Presentation Outline Workshop on Spectrum Management in the Pacific Island 11-15 April 2011 Noumea New Caledonia Spectrum Monitoring French Organization and facilities Thomas Schmidt Agence nationale des

More information

P Colson1,2,3, F Gouriet1,2,3, S Badiaga2,4, C Tamalet1,2, A Stein2,5, D Raoult1,2 (didier.raoult@gmail.com)

P Colson1,2,3, F Gouriet1,2,3, S Badiaga2,4, C Tamalet1,2, A Stein2,5, D Raoult1,2 (didier.raoult@gmail.com) Rapid communication Real-time laboratory surveillance of sexually-transmissible infections in Marseille University hospitals reveals rise of gonorrhoea, syphilis and human immunodeficiency virus seroconversions

More information

THE ROLE OF AGRICULTURE AND FARM HOUSEHOLD DIVERSIFICATION IN THE RURAL ECONOMY OF FRANCE

THE ROLE OF AGRICULTURE AND FARM HOUSEHOLD DIVERSIFICATION IN THE RURAL ECONOMY OF FRANCE TRADE AND AGRICULTURE DIRECTORATE THE ROLE OF AGRICULTURE AND FARM HOUSEHOLD DIVERSIFICATION IN THE RURAL ECONOMY OF FRANCE 1 Foreword This report reviews information on the role of agriculture and farm

More information

Asbestosis and Mesothelioma Among British Asbestos Workers (1971 2005)

Asbestosis and Mesothelioma Among British Asbestos Workers (1971 2005) AMERICAN JOURNAL OF INDUSTRIAL MEDICINE 53:1070 1080 (2010) and Among British Asbestos Workers (1971 2005) Anne-Helen Harding, PhD 1 and Andrew J Darnton, MSc 2 Background Ascertainment of asbestosis and

More information

- Compensation issues

- Compensation issues Charité- Universitätsmedizin Berlin Institut für Arbeitsmedizin Prof. Dr. med. X. Baur Prevention, recognition and compensation of asbestosinduced diseases (AD) - Which diseases are asbestos-related? -

More information

Munich Cancer Registry

Munich Cancer Registry Munich Cancer Registry Baseline statistics Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, 81377 Germany http://www.tumorregister-muenchen.de/en

More information

Asbestos Diseases Uncovered

Asbestos Diseases Uncovered Asbestos Diseases Uncovered Your complete download & keep guide to asbestos-related diseases. Their symptoms, causes and potential compensation payable Contents What is Asbestos? What diseases are caused

More information

Findings from Situational Analyses of Asbestos-Related Diseases in the World

Findings from Situational Analyses of Asbestos-Related Diseases in the World ANZSOM2011 Wellington, NZ Findings from Situational Analyses of Asbestos-Related Diseases in the World University of Occupational & Environmental Health, Japan Acting Director of the WHOCC for Occupational

More information

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology

PRODYNOV. Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI. Image Assisted Laser Therapy for Oncology PRODYNOV Targeted Photodynamic Therapy of Ovarian Peritoneal Carcinomatosis ONCO-THAI Image Assisted Laser Therapy for Oncology Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI

More information

Form of Certification Regarding Correspondent Accounts

Form of Certification Regarding Correspondent Accounts Form of Certification Regarding Correspondent Accounts CERTIFICATION REGARDING CORRESPONDENT ACCOUNTS FOR FOREIGN BANKS [0MB Control Number 1505-0184] The information contained in this Certification is

More information

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1894/06

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1894/06 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1894/06 BEFORE: R. Nairn : Vice-Chair HEARING: September 25, 2006 at Windsor Oral DATE OF DECISION: October 16, 2006 NEUTRAL CITATION: 2006

More information

Testimony of. Dr. James Crapo. April 26, 2005

Testimony of. Dr. James Crapo. April 26, 2005 Testimony of Dr. James Crapo April 26, 2005 Written Statement of Dr. James D. Crapo, Professor of Medicine, National Jewish Medical and Research Center and University of Colorado Health Sciences Center

More information

North Texas School Health Surveillance: First-Year Progress and Next Steps

North Texas School Health Surveillance: First-Year Progress and Next Steps Dean Lampman, MBA, Regional Surveillance Coordinator, Southwest Center for Advanced Public Health Practice* (Fort Worth, TX), dflampman@tarrantcounty.com Tabatha Powell, MPH, Doctoral student, University

More information

CLAIM FORM & DECLARATION FOR THE J T THORPE COMPANY SUCCESSOR TRUST

CLAIM FORM & DECLARATION FOR THE J T THORPE COMPANY SUCCESSOR TRUST CLAIM FORM & DECLARATION FOR THE J T THORPE COMPANY SUCCESSOR TRUST Submit completed claims to: c/o MFR Claims Processing, Inc. 115 Pheasant Run, Suite 112 Newtown, PA, 18940 Telephone: (215) 702-8033

More information

CASE VALUATION MATRIX

CASE VALUATION MATRIX CASE VALUATION MATRIX The Case Valuation Matrix ("Matrix") is designed to approximate historical settlement values in the tort system. To achieve this goal, historical settlement values were evaluated

More information

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST The Celotex Asbestos Settlement Trust (Celotex Trust) was established as a result of the bankruptcy of the Celotex Corporation

More information

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi 27 slides to go Who are we? I am an epidemiologist/biostatistician from the Australian

More information

Instructions for Filing Asbestos Personal Injury Claims

Instructions for Filing Asbestos Personal Injury Claims The Congoleum Plan Trust (the Trust ) was established pursuant to the Fourth Amended Joint Plan of Reorganization Under Chapter 11 of the Bankruptcy Code of the Debtors, the Official Asbestos Claimants

More information

REPUBLIC OF SOUTH AFRICA

REPUBLIC OF SOUTH AFRICA Government Gazette REPUBLC OF SOUTH AFRCA Vol. 448 Pretoria 23 October 2002 No. 23969 ADS HELPLNE: 0800-0123-22 Prevention is the cure ~ 2 No. 23969 GOVERNMENT GAZETTE, 23 OCTOBER 2002 - No. Page Gazette

More information

FITCH AFFIRMS GROUPE BPCE AT 'A'; STABLE OUTLOOK

FITCH AFFIRMS GROUPE BPCE AT 'A'; STABLE OUTLOOK FITCH AFFIRMS GROUPE BPCE AT 'A'; STABLE OUTLOOK Fitch Ratings-Paris/London-23 June 2015: Fitch Ratings has affirmed Groupe BPCE's (GBPCE), BPCE S.A.'s and the group subsidiaries' Long-term Issuer Default

More information

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX The Case Valuation Matrix ( Matrix ) is designed to approximate historical settlement values in the tort system. To achieve

More information

Histological subtypes and survival of malignant mesothelioma patients..

Histological subtypes and survival of malignant mesothelioma patients.. Histological subtypes and survival of malignant mesothelioma patients.. Pr Francoise Galateau-Sallé 1,2, 3 N. Le Stang 1,2, P. Astoul 2,3, P. Brochard 2,3, P. Rolland 2,3, JC. Pairon 2,3, G. Launoy 1,

More information

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF WESTERN ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF WESTERN ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF WESTERN ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX The Case Valuation Matrix ( Matrix ) is designed to approximate historical settlement values in the

More information

Lessons learned from the Western Australian experience with mesothelioma

Lessons learned from the Western Australian experience with mesothelioma Lessons learned from the Western Australian experience with mesothelioma Alison Reid, Western Australian Institute for Medical Research In partnership with Nick de Klerk, Nola Olsen, Jan Sleith, Geoffrey

More information

Trends and geographical patterns of pleural mesotheliomas in the Netherlands 1970-87

Trends and geographical patterns of pleural mesotheliomas in the Netherlands 1970-87 British Journal of ndustrial Medicine 1990;47:775-781 Trends and geographical patterns of pleural mesotheliomas in the Netherlands 1970-87 775 J M M Meijers, H T Planteydt, J J M Slangen, G M H Swaen,

More information

Defending the Mesothelioma Case:

Defending the Mesothelioma Case: Defending the Mesothelioma Case: Types, Alternative Causes, and Working Up the Case Mary Price Birk Baker & Hostetler, LLP 303 East 17 th Avenue, Suite 1100 Denver, CO 80202 (303) 764-4041 (303) 861-7805

More information

Elimination of Asbestos- Related Diseases WHO action. Dr Ivan D. Ivanov Public Health and Environment WHO Headquarters

Elimination of Asbestos- Related Diseases WHO action. Dr Ivan D. Ivanov Public Health and Environment WHO Headquarters Elimination of Asbestos- Related Diseases WHO action Dr Ivan D. Ivanov Public Health and Environment WHO Headquarters Worldwide 125 million people are exposed to asbestos (mostly chrysotile) 75 million

More information

Malignant Mesothelioma: an Update

Malignant Mesothelioma: an Update Malignant Mesothelioma: an Update Nico van Zandwijk Asbestos Diseases Research Institute Bernie Banton Centre University of Sydney Australia Physicians Week RACP 19-5-2009 Health Risks of Asbestos Fibers

More information

Mesothelioma incidence modeling and forecasting

Mesothelioma incidence modeling and forecasting Mesothelioma incidence modeling and forecasting 214 Casualty Loss Reserve Seminar Jorge Gallardo-Garcia, PhD 1973 1976 1979 1982 1985 1988 1991 1994 1997 2 23 26 29 212 215 218 221 224 227 23 233 236 239

More information

What is Mesothelioma?

What is Mesothelioma? What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and

More information

Asbestos Learn more:

Asbestos Learn more: Asbestos Learn more: The Asbestos and Mesothelioma Center http://www.asbestos.com From: http://www.net4truthusa.com/asbestos.htm mirrored on: http://www.vfcll.com/asbestos.htm www.vfcll.com www.net4truthusa.com

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

Burns and Roe Asbestos Personal Injury Settlement Trust Instructions for Filing Claims

Burns and Roe Asbestos Personal Injury Settlement Trust Instructions for Filing Claims The Burns and Roe Asbestos Personal Injury Settlement Trust (the "Trust") was established pursuant to the Plan of Reorganizaton of Burns and Roe Enterprises, Inc., and Burns and Roe Construction Group,

More information

The Burden of Asbestos- Related Disease in British Columbia Final Workshop Report

The Burden of Asbestos- Related Disease in British Columbia Final Workshop Report The Burden of Asbestos- Related Disease in British Columbia Final Workshop Report May 14, 2010 - Vancouver, British Columbia THE BURDEN OF ASBESTOS-RELATED DISEASE IN BC: FINAL WORKSHOP REPORT This report

More information

The performance of the strategy of differentiation of dairy farms in France

The performance of the strategy of differentiation of dairy farms in France Philippe Jeanneaux, Hervé Dakpo and Hélène Blasquiet-Revol The performance of the strategy of differentiation of dairy farms in France JM FAO CIHEAM 2014 June 24-25-26, 2014 - Clermont-Ferrand, France

More information

Mesothelioma among shipyard workers in Monfalcone, Italy

Mesothelioma among shipyard workers in Monfalcone, Italy Original Article Mesothelioma among shipyard workers in Monfalcone, Italy Abstract Background: The high mesothelioma incidence in Monfalcone, Italy, is mainly attributable to shipbuilding activity. Mesothelioma

More information

Silicon Cluster Grenoble Microelectronics ICT and beyond

Silicon Cluster Grenoble Microelectronics ICT and beyond Silicon Cluster Grenoble Microelectronics ICT and beyond Dominique THOMAS STMicroelectronics V. Pequignat E Semet I. Guillaume The Grenoble «Silicon Valleys» 2 Microelectronics in Grenoble Microsystems

More information

Instructions for Filing Claims

Instructions for Filing Claims The ARTRA 524(g) Asbestos Trust (the "Trust") was established as a result of the bankruptcy of the ARTRA Group. The Trust was created to process, liquidate and pay valid asbestos personal injury claims

More information

Babcock & Wilcox Company Asbestos Personal Injury Settlement Trust (Revised August 4, 2009)

Babcock & Wilcox Company Asbestos Personal Injury Settlement Trust (Revised August 4, 2009) Babcock & Wilcox Company Asbestos Personal Injury Settlement Trust (Revised August 4, 2009) July 7, 2006 Dear Prospective Claimant or Claimant Counsel, The Babcock & Wilcox Asbestos Personal Injury Settlement

More information

Plant Asbestos Settlement Trust Claim Form

Plant Asbestos Settlement Trust Claim Form Plant Asbestos Settlement Trust Claim Form Submit completed claim packages to: Plant Asbestos Settlement Trust 300 East Second Street, Suite 1410 Reno, NV 89501 Instructions: (See www.pastrust.com for

More information

Male. Female. Death rates from lung cancer in USA

Male. Female. Death rates from lung cancer in USA Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita

More information

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,

More information

Health Statistics Review of Asbestos- Related Diseases in Three Massachusetts Communities with Potential Human Exposure to Vermiculite Ore

Health Statistics Review of Asbestos- Related Diseases in Three Massachusetts Communities with Potential Human Exposure to Vermiculite Ore Massachusetts Department Of Public Health Health Statistics Review of Asbestos- Related Diseases in Three Massachusetts Communities with Potential Human Exposure to Vermiculite Ore July 2008 Bureau of

More information

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL S.B. 15, the asbestos/silica litigation reform bill, distinguishes between the claims of people who are physically impaired or sick due to exposure

More information